STOCK TITAN

Soleno Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Soleno Therapeutics (NASDAQ: SLNO), a clinical-stage biopharmaceutical company, announced CEO Anish Bhatnagar will participate in two upcoming investor conferences. The Jefferies Global Healthcare Conference is set for June 5, 2024, at 11:30 AM ET, and the Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2024, at 4:00 PM ET. Live audio webcasts and replays will be available on the company's website.

Positive
  • Soleno's participation in high-profile investor conferences may attract new investors and boost its visibility.
  • The company is engaging with the investment community, which can provide strategic insights and potential funding opportunities.
Negative
  • No new clinical data or financial updates were provided in this announcement.
  • Participation in conferences does not guarantee positive stock performance or direct financial benefits.

REDWOOD CITY, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will participate in the following upcoming investor conferences:

EventJefferies Global Healthcare Conference
DayWednesday, June 5, 2024
Time:11:30 AM Eastern Time
  
Event:Goldman Sachs 45th Annual Global Healthcare Conference
Day:Tuesday, June 11, 2024
Time:4:00 PM ET
  

A live audio webcast and replay of the events will be available in the Investors section on the Company’s website at www.soleno.life.

About Soleno Therapeutics, Inc.
Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s lead candidate, DCCR extended-release tablets, a once-daily oral tablet for the treatment of PWS, recently completed its Phase 3 development program to support a planned NDA submission. For more information, please visit www.soleno.life.

Corporate Contact:
Brian Ritchie
LifeSci Advisors, LLC
212-915-2578


FAQ

What is the significance of Soleno Therapeutics (SLNO) participating in the Jefferies Global Healthcare Conference?

Soleno Therapeutics' participation in the Jefferies Global Healthcare Conference enhances its visibility and may attract new investors.

When will Soleno Therapeutics (SLNO) present at the Goldman Sachs 45th Annual Global Healthcare Conference?

Soleno Therapeutics will present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2024, at 4:00 PM ET.

Will there be a live webcast for Soleno Therapeutics' (SLNO) investor conference presentations?

Yes, live audio webcasts and replays of Soleno Therapeutics' presentations will be available on their website.

Who is presenting from Soleno Therapeutics (SLNO) at the upcoming investor conferences?

Anish Bhatnagar, M.D., Chief Executive Officer of Soleno Therapeutics, will present at the conferences.

Soleno Therapeutics, Inc.

NASDAQ:SLNO

SLNO Rankings

SLNO Latest News

SLNO Stock Data

1.95B
39.11M
3.05%
100.97%
11%
Biotechnology
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
REDWOOD CITY